The 2014 Scientific Sessions at the American College of Cardiology highlighted a new class of cholesterol drugs aimed at lowering LDL. These drugs, called PSCK9 inhibitors, may be an effective substitute for widely used statins like Lipitor, Crestor and Zocor. An article by the Cleveland Clinic notes that this class of drugs may prove promising for situations in which statins are either ineffective or not tolerated well by the patient.
An alternative to statins is especially ...
continue reading...